NasdaqGM - Delayed Quote USD

Applied Therapeutics, Inc. (APLT)

Compare
8.72 -0.27 (-3.00%)
At close: October 22 at 4:00 PM EDT
8.73 +0.01 (+0.11%)
After hours: October 22 at 6:27 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
-333.00
9,993.00
--
--
--
--
Operating Expense
77,701.00
74,528.00
82,950.00
105,618.00
94,466.00
--
Operating Income
-78,034.00
-64,535.00
-82,950.00
-105,618.00
-94,466.00
--
Net Non Operating Interest Income Expense
1,959.00
1,372.00
685.00
555.00
559.00
--
Other Income Expense
-85,014.00
-56,600.00
-243.00
-521.00
-54.00
--
Pretax Income
-161,089.00
-119,763.00
-82,508.00
-105,584.00
-93,961.00
--
Net Income Common Stockholders
-161,089.00
-119,763.00
-82,508.00
-105,584.00
-93,961.00
--
Diluted NI Available to Com Stockholders
-161,089.00
-119,763.00
-82,508.00
-105,584.00
-93,961.00
--
Basic EPS
-1.43
-1.42
-2.18
-4.12
-4.28
--
Diluted EPS
-1.43
-1.42
-2.18
-4.12
-4.28
--
Basic Average Shares
117,677.21
84,244.49
37,825.43
25,598.18
21,966.33
--
Diluted Average Shares
117,677.21
84,244.49
37,825.43
25,598.18
21,966.33
--
Total Operating Income as Reported
-78,034.00
-64,535.00
-82,950.00
-105,618.00
-94,466.00
--
Total Expenses
77,701.00
74,528.00
82,950.00
105,618.00
94,466.00
--
Net Income from Continuing & Discontinued Operation
-161,089.00
-119,763.00
-82,508.00
-105,584.00
-93,961.00
--
Normalized Income
-76,191.00
-63,190.00
-82,442.00
-105,584.00
-93,961.00
--
Interest Income
1,959.00
1,372.00
685.00
--
--
--
Net Interest Income
1,959.00
1,372.00
685.00
555.00
559.00
--
EBIT
-78,034.00
-64,535.00
-82,950.00
-105,618.00
-94,466.00
--
EBITDA
-77,668.00
-64,181.00
-82,507.00
-105,203.00
-94,086.00
--
Reconciled Depreciation
366.00
354.00
443.00
415.00
380.00
--
Net Income from Continuing Operation Net Minority Interest
-161,089.00
-119,763.00
-82,508.00
-105,584.00
-93,961.00
--
Total Unusual Items Excluding Goodwill
-84,898.00
-56,573.00
-66.00
--
--
--
Total Unusual Items
-84,898.00
-56,573.00
-66.00
--
--
--
Normalized EBITDA
7,230.00
-7,608.00
-82,441.00
-105,203.00
-94,086.00
--
12/31/2019 - 5/14/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers